STRIGoSUS

transformative medicines for weight loss

We are developing game-changing small molecules to treat excess weight and weight-related medical problems. Using the latest in drug design technology, our molecules will also have beneficial effects on blood pressure, cholesterol, and blood sugar while reducing risk of major cardiovascular events.

First-in-class small molecules for obesity

STRIGOSUS couples cutting edge tools like AI and computational methods with decades of translational medicinal chemistry expertise to target proteins that are intimately tied into obesity and metabolic syndrome. This approach has yielded candidates with unexpected potency for obesity and related conditions.

oral glp-1 agonists

STRIGOSUS is applying deep drug development and technical expertise to harvest the full potential of discrete receptor modulation. Shown is one druggable site on GLP-1R that we have leveraged to deliver breakthrough oral drugs to treat a broad range of patients.